Home
Jennifer Chow - CEO - Chimeric Therapeutics (ASX:CHM) is a clinical-stage therapy company focused on bringing the promise of cell therapy to life for more patients with cancer.
Chimeric Therapeutics (ASX:CHM) - Webinar Presentation
PUBLISHED
2023-10-27
Content
Jennifer Chow - CEO - Chimeric Therapeutics (ASX:CHM) is a clinical-stage therapy company focused on bringing the promise of cell therapy to life for more patients with cancer.
Author
| Name | Finance News Network |